Abstract
The nervous system is the most common site for the development of solid neoplasms in childhood. Neuroblastoma represents a tumor developing at peripheral sites from primitive neuroectodermal cells derived from the neural crests. It very often has a rapidly progressive clinical course. Many advances have been made in understanding the genesis and biology of this tumor which have been translated into better clinical management; however, little improvement in survival rates has been achieved, at least for the large group of patients who have metastatic tumor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alitalo K, Schwab M (1986) Oncogene amplification in tumor cells. Adv Cancer Res 47: 235
Alitalo K, Schwab M, Lin CC, Varmus H, Bishop JM (1983) Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 80: 1707
Amler LC, Schwab M (1989) Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA. Molec Cell Biol 9: 4903
Amler LC, Schwab M (1992) Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA. Oncogene 7: 807
Bartram CR, Berthold F (1987) Amplification and expression of the N-myc gene in neuroblastoma. Eur J Pediatr 146: 162
Beckwith JB and Perrin EV (1963) In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am J Pathol 43:1089
Berthold F (1990) Overview Biology of neuroblastoma. In: Neuroblastoma: Tumor Biology and Therapy. Pochadly, Tebbi, (eds) CRC Press Inc, Boca Raton, p 1
Blackwood EM, Eisenman RN (1991) Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211
Brodeur G, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Sience 224: 1121
Brodeur GM, Green AA, Hayes FA, Williams KG, Williams DL, Tsiatis AA (1981) Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 41: 4678
Carlsen NLT, Christiansen IJ, Schroeder H, Bro PV, Hesselberg K, Jensen KB, Nielsen KH (1986) Prognostic value of different staging systems in neuroblastomas and completeness of tumour exision. Arch Die Child 61: 832
Cohn SL, Herst CV, Maurer HS, Rosen ST (1987) N-myc amplification in an infant with stage IV-s neuroblastoma. J Clin Oncol 5:1441
Cox D, Yuncken C, Spriggs A (1965) Minute chromatin bodies in malignant tumours of childhood. Lancet 2: 55
Douglass EC, Rowe ST, Valentine M, Parham DM, Berkow R, Bowman WP, Maurer HM (1991) Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma. Genes, Chromosomes & Cancer 3: 480
Evans AE, D’Angio GB, Randolph J (1971) A proposed staging for children with neuroblastoma. Cancer 27: 374
Fearon ER, Hamilton SH, Vogelstein B (1987) Clonal analysis of human colorectal tumours. Science 238: 193
Flejter WL, Li FP, Antman KH, Testa JR (1989) Recurring loss involving chromosomes 1, 3 and 22 in malignant mesothelioma: Possible sites of tumor suppressor genes. Genes, Chromosomes and Cancer 1: 148
Fong CT, Dracopoli NC, White PS, Merril PT, Griffith RC, Housman DE, Brodeur GM (1989) Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: Correlation with N-myc amplification. Proc Natl Acad Sci USA 86: 3753
Fuller G, Bigner S (1992) Amplified cellular oncogenes in neoplasms of the central nervous system. Mut Res 276: 299
Garson JA, McIntyre PG, Kemshead JT (1985) N-myc amplification in malignant astrocytoma. The Lancet 8457: 718
Genuardi M, Tshihira H, Anderson DE, Saunders GF (1989) Distal deletion of chromosome 1p in ductal carcinoma of the breast. Amer J Hum Genet 45: 73
Hamann U, Wenzel A, Frank R, Schwab M (1991) The MYCN protein of human neuroblastoma cells is phosphorylated by casein kinase II in the central region and at serine 367. Oncogene 6: 1745
Harnett PR, Kearsley JH, Hayward NK, Dracopoli NC, Kefford RF (1991) Loss of allelic heterozygosity on distal chromosome 1p in Merkel Cell Carcinom. Cancer Genet Cytogenet 54: 109
Hasegawa R, Tatematsu M, Imaida K et al. (1982) Neuroblastoma in situ. Acta Pathol Jpn 32: 537
Kato GJ, Barrett J, Villa-Garcia M, Dang CV (1990) An amino-terminal c-myc domain required for neoplastic transformation activities transcription. Mol Cell Biol 10: 5914
Kohl NE, Kanda N, Schreck RR, Bruns G, Latt SA, Gilbert F, Alt FW (1983) Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35: 359
Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC, Cavanee WK (1985) Loss of heterozygosity in three embryonal tumors suggest a common pathogenetic mechanism. Nature 316: 330
Kramer S, Meadows AT, Jarrett P, Evans AE (1983) Incidence of childhood cancer: experience of a decade in a population-based registry. J Natl Cancers Inst 70: 49
Laureys G, Speleman F, Opdenakker G, Benoit Y, Leroy J (1990) Constitutional translocation t(1;17)(p36;g12–21) in a patient with neuroblastoma. Genes, Chromosomes and Cancer 2: 252
Lee WH, Murphree AL, Benedict WF (1984) Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 309: 458
Leister I, Weith A, Brüderlein S, Cziepluch C, Schlag P, Schwab M (1990) Human colorectal cancer: high frequency of deletions at chromosome 1p35. Cancer Res 50: 7232
Lindström E, Salford LG, Heim S, Mandahl N, Strömblad S, Brun A, Mitelman F (1991) Trisomy 7 and sex chromosome loss need not be representative of tumor parenchyma cells in malignant glioma. Genes, Chromosomes & Cancer 3: 474
Mäkelä, TP, Saksela K, Alitalo K (1989) Two N-myc polypeptides with distinct amino termini encoded by the second and third exons of the gene. Mol Cell Biol 9: 1545
Mäkelä TP, Koskinen PJ, Västrik I, Alitalo K (1992) Alternative forms of Max as enhancers of suppressors of myc-ras cotransformation. Science 256: 373
Martinsson T, Weith A, Cziepluch C, Schwab M (1989) Chromosome 1 deletions in human neuroblastomas: Generation and fine mapping of microclones from the distal 1p region. Genes, Chromosomes and Cancer 1: 67
Michaelis J, Kaatsch P (1986) Cooperative documentation of childhood malignancies in the FRG. System design and five-year results. Monogr Paediatr 18: 56
Nakagawara A, Ikeda K, Tsuda T, Higashi K (1988) Biological characteristics of NMYC amplified neuroblastomas in patients over one year of age. In: Advances in neuroblastoma research; Evans, D’Angio, Seeger (eds). Alan R Liss, Inc. New York, p 31
Nau M, Brooks B, Carney D, Gazdar A, Batey J, Sausville E, Minna J (1986) Human small-cell lung cancers show amplification and expression of the N-myc gene. Proc Natl Acad Sci USA 83: 1092
O’Rourke RW, Miller CW, Kato GJ, Simon KJ, Chen D-L, Dang CV, Koeffler HP (1990) A potential transcriptional activation element in the p53 protein. Oncogene 5: 1829
Rustgi AK, Dyson N, Bernards R (1991) Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 352: 541
Schwab M (1988) The MYC-box oncogenes. In: The Oncogene Handbook; Reddy, Skalka, Curran (eds) Elsevier Science Publishers BV, p 381
Schwab M, Amler LC (1990) Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer. Genes, Chromosomes and Cancer 1: 180
Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblasoma cell lines and a neuroblastoma tumor. Nature 305: 245
Schwab M, Alitalo K, Varmus KH, Bishop JM, George D (1983) A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumor cells. Nature 303: 497
Schwab M, Varmus HE, Bishop JM, Grzeschik KH, Naylor S, Sakaguchi A, Brodeur G, Trent J (1984) Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature 308: 288
Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111
Simon D, Knowles B, Weith A (1991) Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6: 765
Suzuki T, Mugishima H, Fujisawa T, Okumi M, Okabe I, Yokota J, Terada M (1991) Loss of heterozygosity on chromosome 14 in neuroblastoma. In: Advances in Neuroblastoma Reserach; Evans AE, D’Angio GJ, Knudson Jr AG, Seeger RC (eds) Wiley-Liss, Inc, p135
Takayama H, Suzuki T, Mugishima H, Fujisawa T, Ookuni M, Schwab M, Gehring M, Nakamura Y, Sugimura T, Terada M, Yokota J (1992) Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Oncogene 7: 1185
Tonini GP, Verdona G, de Bernardi B, Sansone R, Massimo L, Cornaglia-Ferraris P (1987) N-myc oncogene amplification in a patient with IV-s neuroblastoma. Am J Pediatr Hematol Oncol 9:8
Weith A, Martinsson T, Cziepluch C, Brüderlein S, Amler LC, Berthold F, Schwab M (1989) Neuroblastoma consensus deletion maps to chromosome Ip36.1–2. Genes, Chromosomes and Cancer 1: 159
Wenzel A, Cziepluch C, Hamann U, Schürmann J, Schwab M (1991) The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. EMBO J 10: 3703
Weston K, Bishop JM (1989) Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell 58: 85
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schwab, M. (1994). Human Neuroblastoma: Amplification of the N-myc Oncogene and Loss of a Putative Cancer-Preventing Gene on Chromosome 1p. In: Wiestler, O.D., Schlegel, U., Schramm, J. (eds) Molecular Neuro-oncology and Its Impact on the Clinical Management of Brain Tumors. Recent Results in Cancer Research, vol 135. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85039-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-85039-4_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85041-7
Online ISBN: 978-3-642-85039-4
eBook Packages: Springer Book Archive